nach oben

Indian Journal of Surgical Oncology

Erschienen in:

20.05.2021 | Review Article

Surgical Management of Locoregional Recurrence in Breast Cancer

verfasst von: Ashish Goel, Varun Kumar Agarwal, Vikash Nayak, Rekha Yogsrivas, Abhishek Gulia

Erschienen in: Indian Journal of Surgical Oncology | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Locoregional recurrences from breast cancer represent a heterogeneous group of disease that poses a therapeutic challenge and needs a multidisciplinary team management. The incidence of local recurrence after breast conservation surgery ranges from 10 to 22% and 5–15% after mastectomy at 10-year follow-up. Management of locoregional recurrence depends on tumor biology, stage at presentation, and prior local and systemic therapy. With improvements in diagnostic, pathological, and surgical techniques, radiation and systemic therapy approach, outcomes in these patients have improved. In this review, we discuss the risk factors, prognostic factors, surgical and reconstruction options, re-irradiation, and role of systemic therapy to define a reasonable treatment approach without compromising oncologic safety and achieve good cosmetic and survival outcomes.

(2009) Management of Breast Cancer Recurrence. In: Sabel MS (ed) Essentials of breast surgery, first edn. Mosby Elsevier, 307–322

Van Tienhoven G, Voogd AC, Peterse JL et al (1999) Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomized trials (EORTC10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. Eur J Cancer 35(1):32–38. https://doi.org/10.1016/s0959-8049(98)00301-3CrossRefPubMed

Pisansky TM, Ingle JN, Schaid DJ et al (1993) Patterns of tumor relapse following mastectomy and adjuvant systemic therapy in patients with axillary lymph node-positive breast cancer. Impact of clinical, histopathologic, and flow cytometric factors. Cancer 72(4):1247–1260. https://doi.org/10.1002/1097-0142(19930815)72:4<1247::aid-cncr2820720418>3.0.co;2-s. Erratum in: Cancer 1993 Oct 15;72(8):2524CrossRefPubMed

Wadasadawala T, Vadgaonkar R, Bajpai J (2017) Management of isolated locoregional recurrences in breast cancer: a review of local and systemic modalities. Cancer. 17(7):493–502. https://doi.org/10.1016/j.clbc.2017.03.008CrossRef

Voogd AC, van Oost FJ, Rutgers EJ, Elkhuizen PH, van Geel A, Scheijmans LJ, van der Sangen M, Botke G, Hoekstra CJ, Jobsen JJ, van de Velde C, von Meyenfeldt M, Tabak JM, Peterse JL, van de Vijver M, Coebergh JW, van Tienhoven G, Dutch Study Group on Local Recurrence after Breast Conservation (BORST Group) (2005) Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. Eur J Cancer 41(17):2637–2644. https://doi.org/10.1016/j.ejca.2005.04.040CrossRefPubMed

Borner M, Bacchi M, Goldhirsch A, Greiner R, Harder F, Castiglione M, Jungi WF, Thürlimann B, Cavalli F, Obrecht JP (1994) First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research. J Clin Oncol 12(10):2071–2077. https://doi.org/10.1200/JCO.1994.12.10.2071CrossRefPubMed

Halverson KJ, Perez CA, Kuske RR, Garcia DM, Simpson JR, Fineberg B (1992) Survival following locoregional recurrence of breast cancer: univariate and multivariate analysis. Int J Radiat Oncol Biol Phys 23(2):285–291. https://doi.org/10.1016/0360-3016(92)90743-2CrossRefPubMed

Dershaw DD, McCormick B, Osborne MP (1992) Detection of local recurrence after conservative therapy for breast carcinoma. Cancer. 70(2):493–496. https://doi.org/10.1002/1097-0142(19920715)70:2<493::aid-cncr2820700219>3.0.co;2-3CrossRefPubMed

McGale P, Taylor C et al (2014) Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomized trials. Lancet 383(9935):2127–2135. https://doi.org/10.1016/S0140-6736(14)60488-8CrossRefPubMed

10.

Isasi CR, Moadel RM, Blaufox MD (2005) A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases. Breast Cancer Res Treat 90(2):105–112. https://doi.org/10.1007/s10549-004-3291-7CrossRefPubMed

11.

Faneyte IF, Rutgers EJ, Zoetmulder FA (1997) Chest wall resection in the treatment of locally recurrent breast carcinoma: indications and outcome for 44 patients. Cancer. 80(5):886–891CrossRef

12.

Pfannschmidt J, Geisbüsch P, Muley T, Hoffmann H, Dienemann H (2005) Surgical resection of secondary chest wall tumors. Thorac Cardiovasc Surg 53:234–239. https://doi.org/10.1055/s-2005-837649CrossRefPubMed

13.

Doyle T, Schultz DJ, Peters C, Harris E, Solin LJ (2001) Long-term results of local recurrence after breast conservation treatment for invasive breast cancer. Int J Radiat Oncol Biol Phys 51(1):74–80. https://doi.org/10.1016/s0360-3016(01)01625-xCrossRefPubMed

14.

Kurtz JM, Jacquemier J, Brandone H et al (1991) Inoperable recurrence after breast-conserving surgical treatment and radiotherapy. Surg Gynecol Obstet 172(5):357–361PubMed

15.

Alpert TE, Kuerer HM, Arthur DW, Lannin DR, Haffty BG (2005) Ipsilateral breast tumor recurrence after breast conservation therapy: outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation. Int J Radiat Oncol Biol Phys 63(3):845–851. https://doi.org/10.1016/j.ijrobp.2005.02.035CrossRefPubMed

16.

McCready DR, Fish EB, Hiraki GY et al (1992) Total mastectomy is not always mandatory for the treatment of recurrent breast cancer after lumpectomy alone. Can J Surg 35(5):485–488 Erratum in: Can J Surg 1992 Dec;35(6):641PubMed

17.

Gentilini O, Botteri E, Veronesi P, Sangalli C, del Castillo A, Ballardini B, Galimberti V, Rietjens M, Colleoni M, Luini A, Veronesi U (2012) Repeating conservative surgery after ipsilateral breast tumor reappearance: criteria for selecting the best candidates. Ann Surg Oncol 19(12):3771–3776. https://doi.org/10.1245/s10434-012-2404-5CrossRefPubMed

18.

Poodt I, Walstra CJEF, Vugts G et al (2019) Low risk of development of a regional recurrence after an unsuccessful repeat sentinel lymph node biopsy in patients with ipsilateral breast tumor recurrence. Ann Surg Oncol 26(8):2417–2427. https://doi.org/10.1245/s10434-019-07272-4CrossRefPubMed

19.

Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham DL, Deutsch M, Montague E, Margolese R, Foster R (1985) Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312(11):674–681. https://doi.org/10.1056/NEJM198503143121102CrossRefPubMed

20.

De Boer R, Hillen HF, Roumen RM et al (2001) Detection, treatment and outcome of axillary recurrence after axillary clearance for invasive breast cancer. Br J Surg 88(1):118–122. https://doi.org/10.1046/j.1365-2168.2001.01637.xCrossRefPubMed

21.

Lukens JN, Vapiwala N, Hwang W-T, Solin LJ (2009) Regional nodal recurrence after breast conservation treatment with radiotherapy for women with early-stage breast carcinoma. Int J Radiat Oncol Biol Phys 73(5):1475–1481. https://doi.org/10.1016/j.ijrobp.2008.06.1955CrossRefPubMed

22.

Silverstein MJ, Savalia N, Khan S, Ryan J (2015) Extreme oncoplasty: breast conservation for patients who need mastectomy. Breast J 21(1):52–59. https://doi.org/10.1111/tbj.12356CrossRefPubMedPubMedCentral

23.

Momoh AO, Ahmed R, Kelley BP, Aliu O, Kidwell KM, Kozlow JH, Chung KC (2014) A systematic review of complications of implant based breast reconstruction with pre reconstruction and post reconstruction radiotherapy. Ann Surg Oncol 21(1):118–124. https://doi.org/10.1245/s10434-013-3284-zCrossRefPubMed

24.

Williams JK, Bostwick J 3rd, Bried JT, Mackay G, Landry J, Benton J (1995) TRAM flap breast reconstruction after radiation treatment. Ann Surg 221(6):756–766. https://doi.org/10.1097/00000658-199506000-00014CrossRefPubMedPubMedCentral

25.

Cordeiro PG, Snell L, Heerdt A, McCarthy C (2012) Immediate tissue expander/implant breast reconstruction after salvage mastectomy for cancer recurrence following lumpectomy/irradiation. Plast Reconstr Surg 129(2):341–350. https://doi.org/10.1097/PRS.0b013e318205f203CrossRefPubMed

26.

Lam TC, Hsieh F, Salinas J, Boyages J (2015) Can an immediate 2-stage breast reconstruction be performed after previous conservative surgery and radiotherapy? Plast Reconstr Surg Glob Open 3(7):e473. Published 2015 Aug 10. https://doi.org/10.1097/GOX.0000000000000436CrossRefPubMedPubMedCentral

27.

Chetta MD, Aliu O, Zhong L, Sears ED, Waljee JF, Chung KC, Momoh AO (2017) Reconstruction of the irradiated breast: a national claims based assessment of postoperative morbidity. Plast Reconstr Surg 139(4):783–792. https://doi.org/10.1097/PRS.0000000000003168CrossRefPubMedPubMedCentral

28.

Fischer JP, Basta MN, Shubinets V, Serletti JM, Fosnot J (2016) A systematic meta-analysis of prosthetic-based breast reconstruction in irradiated fields with or without autologous muscle flap coverage. Ann Plast Surg 77(1):129–134. https://doi.org/10.1097/SAP.0000000000000288CrossRefPubMed

29.

O’Connell RL, Di Micco R, Khabra K et al (2018) Comparison of immediate versus delayed DIEP flap reconstruction in women who require post mastectomy radiotherapy. Plast Reconstr Surg 142(3):594–605. https://doi.org/10.1097/PRS.0000000000004676CrossRefPubMedPubMedCentral

30.

Clarke-Pearson EM, Chadha M, Dayan E, Dayan JH, Samson W, Sultan MR, Smith ML (2013) Comparison of irradiated versus non-irradiated DIEP flaps in patients undergoing immediate bilateral DIEP reconstruction with unilateral post mastectomy radiation therapy (PMRT). Ann Plast Surg 71(3):250–254. https://doi.org/10.1097/SAP.0b013e31828986ecCrossRefPubMed

31.

Taghizadeh R, Moustaki M, Harris S, Roblin P, Farhadi J (2015) Does post-mastectomy radiotherapy affect the outcome and prevalence of complications in immediate DIEP breast reconstruction? A prospective cohort study. J Plast Reconstr Aesthet Surg 68(10):1379–1385. https://doi.org/10.1016/j.bjps.2015.06.003CrossRefPubMed

32.

Wahl AO, Rademaker A, Kiel KD, Jones EL, Marks LB, Croog V, McCormick BM, Hirsch A, Karkar A, Motwani SB, Tereffe W, Yu TK, Sher D, Silverstein J, Kachnic LA, Kesslering C, Freedman GM, Small W Jr (2008) Multi-institutional review of repeat irradiation of chest wall and breast for recurrent breast cancer. Int J Radiat Oncol Biol Phys 70(2):477–484. https://doi.org/10.1016/j.ijrobp.2007.06.035CrossRefPubMed

33.

Kauer-Dorner D, Pötter R, Resch A, Handl-Zeller L, Kirchheiner Mag K, Meyer-Schell K, Dörr W (2012) Partial breast irradiation for locally recurrent breast cancer within a second breast conserving treatment: alternative to mastectomy? Results from a prospective trial. Radiother Oncol 102(1):96–101. https://doi.org/10.1016/j.radonc.2011.07.020CrossRefPubMed

34.

Elkort RJ, Kelly W, Mozden PJ, Feldman MI (1980) A combined treatment program for the management of locally recurrent breast cancer following chest wall irradiation. Cancer. 46(4):647–653. https://doi.org/10.1002/1097-0142(19800815)46:4CrossRefPubMed

35.

Aebi S, Gelber S, Anderson SJ, Láng I, Robidoux A, Martín M, Nortier JW, Paterson AH, Rimawi MF, Cañada JM, Thürlimann B, Murray E, Mamounas EP, Geyer CE Jr, Price KN, Coates AS, Gelber RD, Rastogi P, Wolmark N, Wapnir IL, CALOR investigators (2014) Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomized trial. Lancet Oncol 15(2):156–163. https://doi.org/10.1016/S1470-2045(13)70589-8CrossRefPubMedPubMedCentral

36.

Waeber M, Castiglione-Gertsch M, Dietrich D, Thürlimann B, Goldhirsch A, Brunner KW, Borner MM, Swiss Group for Clinical Cancer Research (SAKK) (2003) Adjuvant therapy after excision and radiation of isolated post mastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23/82) comparing tamoxifen with observation. Ann Oncol 14(8):1215–1221. https://doi.org/10.1093/annonc/mdg347CrossRefPubMed

37.

Furey PC, Macgillivray DC, Castiglione CL, Allen L (1994) Wound complications in patients receiving adjuvant chemotherapy after mastectomy and immediate breast reconstruction for breast cancer. J Surg Oncol 55(3):194–197. https://doi.org/10.1002/jso.2930550313CrossRefPubMed

38.

Caffo O, Cazzolli D, Scalet A, Zani B, Ambrosini G, Amichetti M, Bernardi D, Brugnara S, Ciaghi G, Lucenti A, Natale N, Agugiaro S, Eccher C, Galligioni E (2000) Concurrent adjuvant chemotherapy and immediate breast reconstruction with skin expanders after mastectomy for breast cancer. Breast Cancer Res Treat 60(3):267–275. https://doi.org/10.1023/a:1006401403249CrossRefPubMed

39.

Warren Peled A, Itakura K, Foster RD, Hamolsky D, Tanaka J, Ewing C, Alvarado M, Esserman LJ, Hwang ES (2010) Impact of chemotherapy on postoperative complications after mastectomy and immediate breast reconstruction. Arch Surg 145(9):880–885. https://doi.org/10.1001/archsurg.2010.163CrossRefPubMed

40.

Alderman AK, Collins ED, Schott A, Hughes ME, Ottesen RA, Theriault RL, Wong YN, Weeks JC, Niland JC, Edge SB (2010) The impact of breast reconstruction on the delivery of chemotherapy. Cancer. 116(7):1791–1800. https://doi.org/10.1002/cncr.24891CrossRefPubMed

41.

Giacalone PL, Rathat G, Daures JP, Benos P, Azria D, Rouleau C (2010) New concept for immediate breast reconstruction for invasive cancers: feasibility, oncological safety and aesthetic outcome of post-neoadjuvant therapy immediate breast reconstruction versus delayed breast reconstruction: a prospective pilot study. Breast Cancer Res Treat 122(2):439–451. https://doi.org/10.1007/s10549-010-0951-7CrossRefPubMed

42.

Harmeling JX, Kouwenberg CAE, Bijlard E et al (2015) The effect of immediate breast reconstruction on the timing of adjuvant chemotherapy: a systematic review. Breast Cancer Res Treat 153(2):241–251. https://doi.org/10.1007/s10549-015-3539-4CrossRef

Titel: Surgical Management of Locoregional Recurrence in Breast Cancer
verfasst von: Ashish Goel
Varun Kumar Agarwal
Vikash Nayak
Rekha Yogsrivas
Abhishek Gulia
Publikationsdatum: 20.05.2021
Verlag: Springer India
Erschienen in: Indian Journal of Surgical Oncology / Ausgabe 3/2021
Print ISSN: 0975-7651
Elektronische ISSN: 0976-6952
DOI: https://doi.org/10.1007/s13193-021-01342-4

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich

weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2021

Bone Marrow Metastases from Solid Organ Cancer in Adults

Contemporary Surgical, Oncological, and Survival Outcomes of Pancreaticoduodenectomy for Periampullary Tumours: a 5-Year Experience from Tertiary Cancer Center

Correction to: An Initial Experience of Shoulder Resections and Reconstruction for Bone Tumours from a Cancer Centre in North-East India

Estimation of Serum MicroRNA 21 as a Tumour Marker in Carcinoma Oesophagus

Effect of Preoperative Biliary Stenting on Outcomes of Pancreaticoduodenectomy

Practicing Surgical Pathology at a Distance, Need of the Hour: Our Experience of a Single Tertiary Care Referral Cancer Centre Observational Study from Western India During Covid-19 Pandemic

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Hinter dieser Appendizitis steckte ein Erreger

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Ureterstriktur: Innovative OP-Technik bewährt sich

Update Chirurgie

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

S2e-Leitlinie „Distale Radiusfraktur“

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“